🟢 87/100

This product is generally safe

  • Fish Oil concentrate: 4000mg is 1.3× the Tolerable Upper Intake Level (3000mg)
  • 33% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Fish Oil concentrate: 4000mg is 1.3× the Tolerable Upper Intake Level (3000mg)

Label Data

4 Capsule(s) Serving Size
30 Servings
Fat/Fatty Acid Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calories
35 {Calories}
Total Fat
4 Gram(s) (6% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.3× (UL: 3000 mg) 📚 388 studies (Tier A: 18, B: 204)
This product: 4000mg UL 3000mg

Other Ingredients

EPA Fish oil concentrate DHA Gelatin Glycerin purified Water proprietary antioxidant blend Titanium Dioxide

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

⚠️ Warnings & Precautions

CONTAINS: FISH.

🧪 Formulation Notes

Omega-3 EPA/DHA Concentrate

CONTAINS: FISH.

Additional Information

Looking for the best fish oil supplement? The quality of any fish oil product can be judged by the levels of contaminants, such as PCBs, found in the oil. Any company that states their fish oil is free of PCBs is simply not honest. OmegaRx has a lower level of PCBs than prescription fish oil but at a fraction of the cost. Benefits of OmegaRx: Reduces cellular inflammation. Supports mental acuity and long-term cognitive health. Enhances joint dexterity, reduces joint aches and pains. Helps maintain a healthy heart.

ULTRA-REFINED

Product Details

DSLD Entry Date 2013-11-25
Product Type Fat/Fatty Acid
Form Capsule
DSLD ID 27748
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →